Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort

Fig. 1

Kaplan-Meier survival curves for high versus low biomarker levels using a cut-off of 50.7ng2/mL2 for PRO-C6*VWF-N and 116.5ng2/mL2 for PRO-C6*VWF-A. Individuals with high biomarker levels of PRO-C6*VWF-N and PRO-C6*VWF-A showed a higher number of deaths (n = 22 and n = 15) within the study period compared to subjects with low biomarker levels of PRO-C6*VWF-N and PRO-C6*VWF-A (n = 5 and n = 12)

Back to article page